Justin Jun Wei

Title: Innovations by Justin Jun Wei in Injectable Epinephrine Formulations

Introduction

Justin Jun Wei is an accomplished inventor based in Chino Hills, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of injectable epinephrine formulations. His work focuses on enhancing the stability and retention of epinephrine over extended periods, which is crucial for medical applications.

Latest Patents

Justin Jun Wei holds a patent for "Injectable epinephrine formulations demonstrating stability over time." This innovative formulation includes epinephrine with increased retention capabilities, ensuring that it remains effective even after long-term storage of up to 30 months. The formulation comprises specific concentrations of epinephrine, sodium chloride, sodium citrate dihydrate, citric acid monohydrate, sodium hydroxide, sodium metabisulfite, and ethylene diamine tetra-acetate disodium. Remarkably, the formulation achieves an API recovery of 94.5% or more after 30 months under defined storage conditions.

Career Highlights

Justin is associated with Amphastar Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work is pivotal in creating reliable pharmaceutical products that can significantly impact patient care.

Collaborations

Throughout his career, Justin has collaborated with notable colleagues, including Jie Fei Ding and Marvin Lin. These partnerships have fostered a collaborative environment that enhances innovation and drives successful outcomes in their projects.

Conclusion

Justin Jun Wei's contributions to injectable epinephrine formulations exemplify the importance of innovation in the pharmaceutical industry. His work not only improves the stability of essential medications but also enhances patient safety and treatment efficacy.